Total Payments
$310,565
2024 Payments
$66,219
Companies
55
Transactions
952
Medicare Patients
15,734
Medicare Billing
$749,454
Payment Breakdown by Category
Other$267,023 (86.0%)
Food & Beverage$18,471 (5.9%)
Travel$17,939 (5.8%)
Consulting$6,988 (2.2%)
Education$144.20 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $267,023 | 78 | 86.0% |
| Food and Beverage | $18,471 | 777 | 5.9% |
| Travel and Lodging | $17,939 | 81 | 5.8% |
| Consulting Fee | $6,988 | 9 | 2.2% |
| Education | $144.20 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $198,513 | 164 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45,390 | 73 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $28,434 | 264 | $0 (2023) |
| Lilly USA, LLC | $14,766 | 26 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $7,467 | 44 | $0 (2024) |
| Abbott Laboratories | $2,368 | 49 | $0 (2024) |
| Penumbra, Inc. | $2,298 | 6 | $0 (2024) |
| ABIOMED | $1,605 | 25 | $0 (2024) |
| Terumo Medical Corporation | $1,563 | 13 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,257 | 63 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $66,219 | 135 | Novo Nordisk Inc ($54,166) |
| 2023 | $55,660 | 120 | Novo Nordisk Inc ($49,811) |
| 2022 | $78,402 | 134 | Novo Nordisk Inc ($47,405) |
| 2021 | $56,916 | 123 | Novo Nordisk Inc ($46,858) |
| 2020 | $5,731 | 84 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,800) |
| 2019 | $31,065 | 148 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,715) |
| 2018 | $14,707 | 113 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,081) |
| 2017 | $1,864 | 95 | Terumo Medical Corporation ($642.72) |
All Payment Transactions
952 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.11 | General |
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/22/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,943.75 | General |
| 11/05/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Stents | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,331.25 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $575.83 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $574.33 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $403.90 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $136.44 | General |
| 10/16/2024 | Novo Nordisk Inc | — | Travel and Lodging | In-kind items and services | $15.00 | General |
| 10/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,589 | 4,891 | $470,683 | $171,253 |
| 2022 | 39 | 3,709 | 5,436 | $483,563 | $170,135 |
| 2021 | 38 | 3,949 | 5,870 | $532,280 | $189,593 |
| 2020 | 40 | 4,487 | 6,545 | $597,865 | $218,473 |
Total Patients
15,734
Total Services
22,742
Medicare Billing
$749,454
Procedure Codes
161
All Medicare Procedures & Services
161 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 243 | 340 | $82,620 | $29,829 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 330 | 413 | $71,036 | $24,600 | 34.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 277 | 284 | $38,624 | $14,311 | 37.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 158 | $30,968 | $14,107 | 45.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 112 | 116 | $30,044 | $11,230 | 37.4% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 50 | 50 | $28,350 | $9,572 | 33.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 128 | 129 | $19,350 | $7,319 | 37.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 464 | 739 | $19,953 | $7,271 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 55 | 55 | $17,490 | $6,392 | 36.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 15 | 16 | $18,112 | $6,305 | 34.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 57 | 74 | $10,138 | $4,413 | 43.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 492 | 772 | $12,352 | $4,301 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 32 | $10,976 | $4,007 | 36.5% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 79 | 116 | $6,844 | $2,515 | 36.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 54 | 123 | $6,273 | $2,384 | 38.0% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 109 | 155 | $6,510 | $2,360 | 36.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 24 | 27 | $5,616 | $2,099 | 37.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 79 | 84 | $5,544 | $2,082 | 37.6% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 22 | 24 | $5,040 | $1,904 | 37.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 61 | 61 | $4,636 | $1,706 | 36.8% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 139 | 144 | $4,032 | $1,499 | 37.2% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 53 | 197 | $4,334 | $1,459 | 33.7% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 157 | 159 | $3,816 | $1,375 | 36.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 86 | 105 | $3,591 | $990.15 | 27.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 30 | 35 | $2,555 | $933.76 | 36.5% |
About Dr. Steve Lin, MD
Dr. Steve Lin, MD is a Cardiovascular Disease healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518979111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steve Lin, MD has received a total of $310,565 in payments from pharmaceutical and medical device companies, with $66,219 received in 2024. These payments were reported across 952 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($267,023).
As a Medicare-enrolled provider, Lin has provided services to 15,734 Medicare beneficiaries, totaling 22,742 services with total Medicare billing of $749,454. Data is available for 4 years (2020–2023), covering 161 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Nuclear Cardiology
- Location Lexington, KY
- Active Since 08/12/2006
- Last Updated 04/08/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518979111
Products in Payments
- JARDIANCE (Drug) $60,085
- Ozempic (Drug) $52,437
- XARELTO (Drug) $28,563
- Rybelsus (Drug) $21,657
- Wegovy (Drug) $17,334
- RYBELSUS (Drug) $6,445
- FARXIGA (Drug) $4,150
- LOKELMA (Drug) $2,494
- Indigo System (Device) $2,141
- CardioMEMS HF System (Device) $1,678
- Impella (Device) $1,605
- ONYX FRONTIER (Device) $1,244
- ENTRESTO (Drug) $961.06
- NAVICROSS (Device) $843.16
- BRILINTA (Drug) $801.77
- COOK MEDICAL FILTERS (Device) $525.83
- CARDIOMEMS (Device) $433.23
- Repatha (Biological) $413.52
- LEQVIO (Drug) $295.58
- MULTAQ (Drug) $291.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lexington
Dr. William Skinner, Md, MD
Cardiovascular Disease — Payments: $463,034
Cardiovascular Disease $463,034
Dr. Joseph Souza, M.d, M.D
Cardiovascular Disease — Payments: $238,102
Cardiovascular Disease $238,102
Gery Tomassoni, M.d, M.D
Cardiovascular Disease — Payments: $215,300
Cardiovascular Disease $215,300
Armaghan Soomro, Md, MD
Cardiovascular Disease — Payments: $114,497
Cardiovascular Disease $114,497
Dr. Adrian Messerli, Md, MD
Cardiovascular Disease — Payments: $67,777
Cardiovascular Disease $67,777
Himadri Dasgupta, Md, MD
Cardiovascular Disease — Payments: $42,982
Cardiovascular Disease $42,982